Cart Icon0
Menu

Search from website

Human IgG1-kappa antibody to SARS CoV-2 NP (clone 82C3)

 

Figure 1. Simply Blue Safe Stained SDS-PAGE analysis of monoclonal antibody to SARS-CoV-2 Nucleocapsid protein, clone 82C3. 4-15% gradient gel is used for analysis. Lane 1. Monoclonal antibody to SARS-CoV-2 Nucleocapsid protein, clone 82C3 (+DTT). Lane 2. Size marker. Lane 3. Monoclonal antibody to SARS-CoV-2 Nucleocapsid protein, clone 82C3 (-DTT).

       

Figure 2. HPLC analytical SEC for final product.

       

Figure 3. HPLC analytical SEC after 3 freeze-thaw cycles.

       

Figure 4. Octet RED96e analysis, different concentrations of antibody (200, 100,50,25 and 12.5 nM) was loaded on sensor for capture of Nucleocapsid protein.

     

Select volume:

Quantity:

Catalogue #

R1-179-100

Name

Human IgG1-kappa antibody to SARS CoV-2 NP (clone 82C3)

Target

Nucleocapsid protein SARS-CoV-2

Target Description

Recombinant SARS-CoV-2 Nucleocapsid protein produced by CHO-based Icosagen Cell factory Ltd. proprietary suspension cell line

Uniprot ID

P0DTC9

Clonality

Human monoclonal

Clone

82C3

Class

hIgG1

Reactivity

SARS-CoV-2 Nucleocapsid protein

Application

ELISA

Protocol

Monoclonal antibody working amount has to be established practically for each particular antigen and assay format.

Purification

Protein A affinity chromatography followed by desalting

Concentration

1 mg/ml

Buffer

PBS pH 7.4

QC

SDS-PAGE, Octet binding, ELISA

Shipping

Shipped on dry ice.

Storage

Store in -65...-85 °C. Avoid multiple freeze-thaw cycles.

This product is for research use only

TECHNICAL ASSISTANCE

Please refer any technical questions to

technical.support@icosagen.com

Our locations

United States Office

77 Geary St. 5th Floor
San Francisco, CA 94108

European Office

Eerika tee 1
Õssu, Kambja vald
Tartu maakond 61713
Estonia
+372 737 7070
Shopping Cart